PLK1-Targeted Fluorescent Tumor Imaging with High Signal-to-Background Ratio

Ji Ting Hou, Kyung Phil Ko, Hu Shi, Wen Xiu Ren, Peter Verwilst, Seyoung Koo, Jin Yong Lee, Sung-Gil Chi, Jong Seung Kim

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

As significantly expressed during cell division, polo-like kinase 1 (PLK1) plays crucial roles in numerous mitotic events and has attracted interest as a potential therapeutic marker in oncological drug discovery. We prepared two small molecular fluorescent probes, 1 and 2, conjugated to SBE13 (a type II PLK1 inhibitor) to investigate the PLK1-targeted imaging of cancer cells and tumors. Enzymatic docking studies, molecular dynamics simulations, and in vitro and in vivo imaging experiments all supported the selective targeting and visualization of PLK1 expressing cells by probes 1 and 2, and probe 2 was successfully demonstrated to image PLK1-upregulated tumors with remarkable signal-to-background ratios. These findings represent the first example of small-molecule based fluorescent imaging of tumors using PLK1 as a target, which could provide new avenues for tumor diagnosis and precision therapeutics.

Original languageEnglish
Pages (from-to)1512-1516
Number of pages5
JournalACS Sensors
Volume2
Issue number10
DOIs
Publication statusPublished - 2017 Oct 27

Fingerprint

Tumors
tumors
Imaging techniques
probes
Cells
cell division
markers
inhibitors
Molecular dynamics
drugs
Visualization
cancer
molecular dynamics
Fluorescent Dyes
Molecules
polo-like kinase 1
Computer simulation
cells
molecules
simulation

Keywords

  • fluorescence
  • high SBR ratio
  • PLK1
  • SBE13
  • targeted imaging

ASJC Scopus subject areas

  • Bioengineering
  • Fluid Flow and Transfer Processes
  • Process Chemistry and Technology
  • Instrumentation

Cite this

PLK1-Targeted Fluorescent Tumor Imaging with High Signal-to-Background Ratio. / Hou, Ji Ting; Ko, Kyung Phil; Shi, Hu; Ren, Wen Xiu; Verwilst, Peter; Koo, Seyoung; Lee, Jin Yong; Chi, Sung-Gil; Kim, Jong Seung.

In: ACS Sensors, Vol. 2, No. 10, 27.10.2017, p. 1512-1516.

Research output: Contribution to journalArticle

Hou, JT, Ko, KP, Shi, H, Ren, WX, Verwilst, P, Koo, S, Lee, JY, Chi, S-G & Kim, JS 2017, 'PLK1-Targeted Fluorescent Tumor Imaging with High Signal-to-Background Ratio', ACS Sensors, vol. 2, no. 10, pp. 1512-1516. https://doi.org/10.1021/acssensors.7b00544
Hou JT, Ko KP, Shi H, Ren WX, Verwilst P, Koo S et al. PLK1-Targeted Fluorescent Tumor Imaging with High Signal-to-Background Ratio. ACS Sensors. 2017 Oct 27;2(10):1512-1516. https://doi.org/10.1021/acssensors.7b00544
Hou, Ji Ting ; Ko, Kyung Phil ; Shi, Hu ; Ren, Wen Xiu ; Verwilst, Peter ; Koo, Seyoung ; Lee, Jin Yong ; Chi, Sung-Gil ; Kim, Jong Seung. / PLK1-Targeted Fluorescent Tumor Imaging with High Signal-to-Background Ratio. In: ACS Sensors. 2017 ; Vol. 2, No. 10. pp. 1512-1516.
@article{baa77acdb4594301a8717ad36d1de0f8,
title = "PLK1-Targeted Fluorescent Tumor Imaging with High Signal-to-Background Ratio",
abstract = "As significantly expressed during cell division, polo-like kinase 1 (PLK1) plays crucial roles in numerous mitotic events and has attracted interest as a potential therapeutic marker in oncological drug discovery. We prepared two small molecular fluorescent probes, 1 and 2, conjugated to SBE13 (a type II PLK1 inhibitor) to investigate the PLK1-targeted imaging of cancer cells and tumors. Enzymatic docking studies, molecular dynamics simulations, and in vitro and in vivo imaging experiments all supported the selective targeting and visualization of PLK1 expressing cells by probes 1 and 2, and probe 2 was successfully demonstrated to image PLK1-upregulated tumors with remarkable signal-to-background ratios. These findings represent the first example of small-molecule based fluorescent imaging of tumors using PLK1 as a target, which could provide new avenues for tumor diagnosis and precision therapeutics.",
keywords = "fluorescence, high SBR ratio, PLK1, SBE13, targeted imaging",
author = "Hou, {Ji Ting} and Ko, {Kyung Phil} and Hu Shi and Ren, {Wen Xiu} and Peter Verwilst and Seyoung Koo and Lee, {Jin Yong} and Sung-Gil Chi and Kim, {Jong Seung}",
year = "2017",
month = "10",
day = "27",
doi = "10.1021/acssensors.7b00544",
language = "English",
volume = "2",
pages = "1512--1516",
journal = "ACS Sensors",
issn = "2379-3694",
publisher = "American Chemical Society",
number = "10",

}

TY - JOUR

T1 - PLK1-Targeted Fluorescent Tumor Imaging with High Signal-to-Background Ratio

AU - Hou, Ji Ting

AU - Ko, Kyung Phil

AU - Shi, Hu

AU - Ren, Wen Xiu

AU - Verwilst, Peter

AU - Koo, Seyoung

AU - Lee, Jin Yong

AU - Chi, Sung-Gil

AU - Kim, Jong Seung

PY - 2017/10/27

Y1 - 2017/10/27

N2 - As significantly expressed during cell division, polo-like kinase 1 (PLK1) plays crucial roles in numerous mitotic events and has attracted interest as a potential therapeutic marker in oncological drug discovery. We prepared two small molecular fluorescent probes, 1 and 2, conjugated to SBE13 (a type II PLK1 inhibitor) to investigate the PLK1-targeted imaging of cancer cells and tumors. Enzymatic docking studies, molecular dynamics simulations, and in vitro and in vivo imaging experiments all supported the selective targeting and visualization of PLK1 expressing cells by probes 1 and 2, and probe 2 was successfully demonstrated to image PLK1-upregulated tumors with remarkable signal-to-background ratios. These findings represent the first example of small-molecule based fluorescent imaging of tumors using PLK1 as a target, which could provide new avenues for tumor diagnosis and precision therapeutics.

AB - As significantly expressed during cell division, polo-like kinase 1 (PLK1) plays crucial roles in numerous mitotic events and has attracted interest as a potential therapeutic marker in oncological drug discovery. We prepared two small molecular fluorescent probes, 1 and 2, conjugated to SBE13 (a type II PLK1 inhibitor) to investigate the PLK1-targeted imaging of cancer cells and tumors. Enzymatic docking studies, molecular dynamics simulations, and in vitro and in vivo imaging experiments all supported the selective targeting and visualization of PLK1 expressing cells by probes 1 and 2, and probe 2 was successfully demonstrated to image PLK1-upregulated tumors with remarkable signal-to-background ratios. These findings represent the first example of small-molecule based fluorescent imaging of tumors using PLK1 as a target, which could provide new avenues for tumor diagnosis and precision therapeutics.

KW - fluorescence

KW - high SBR ratio

KW - PLK1

KW - SBE13

KW - targeted imaging

UR - http://www.scopus.com/inward/record.url?scp=85032619658&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032619658&partnerID=8YFLogxK

U2 - 10.1021/acssensors.7b00544

DO - 10.1021/acssensors.7b00544

M3 - Article

VL - 2

SP - 1512

EP - 1516

JO - ACS Sensors

JF - ACS Sensors

SN - 2379-3694

IS - 10

ER -